Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma

Clinical and Translational Oncology

Volumn 14, Issue 5, 2012, Pages 391-395

  Kim, Kyubo ^a   Chie, Eui Kyu ^a   Jang, Jin Young ^a   Kim, Sun Whe ^a   Han, Sae Won ^a   Oh, Do Youn ^a   Im, Seock Ah ^a   Kim, Tae You ^a   Bang, Yung Jue ^a   Ha, Sung W ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Adjuvant chemoradiotherapy; Location; Pancreas; Periampullary adenocarcinoma

Indexed keywords

FLUOROURACIL;

ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DUODENUM CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PERIAMPULLARY ADENOCARCINOMA; RADIATION DOSE; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME; VATER PAPILLA;

ADENOCARCINOMA; ADULT; AGED; AMPULLA OF VATER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; COMMON BILE DUCT NEOPLASMS; DUODENAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84860754168     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0814-2     Document Type: Article

References (21)

1. Yeo CJ, Cameron JL, Sohn TA et al (1997) Six hundred fi fty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg 226:248-260
2. Connolly MM, Dawson PJ, Michelassi F et al (1987) Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 206:366-373 (Pubitemid 17159711)
3. Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006-2010
4. Klinkenbijl JH, Jeekel J, Sahmoud T et al (1999) Adjuvant radiotherapy and 5-fl uorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Ann Surg 230:776-782
5. Neoptolemos JP, Stocken DD, Friess H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210 (Pubitemid 38339364)
6. Bouvet M, Gamagami RA, Gilpin EA et al (2000) Factors influencing survival after resection for periampullary neoplasms. Am J Surg 180:13-17
7. Schmidt CM, Powell ES, Yiannoutsos CT et al (2004) Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 139:718-727 (Pubitemid 38886504)
8. de Castro SM, Kuhlmann KF, van Heek NT et al (2004) Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. J Gastrointest Surg 8:775-784 (Pubitemid 41115730)
9. Lee JH, Whittington R, Williams NN et al (2000) Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 47:945-953 (Pubitemid 30345592)
10. Mehta VK, Fisher GA, Ford JM et al (2001) Adjuvant chemoradiotherapy for "unfavorable" carcinoma of the ampulla of Vater. Arch Surg 136: 65-69 (Pubitemid 32064123)
11. Kim K, Chie EK, Jang JY et al (2009) Role of adjuvant chemoradiotherapy for ampulla of Vater cancer. Int J Radiat Oncol Biol Phys 75:436-441
12. Serafi ni FM, Sachs D, Bloomston M et al (2001) Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Am Surg 67:839-844
13. Kim K, Chie EK, Jang JY et al (2010) Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer? Int J Radiat Oncol Biol Phys 77:1186-1190
14. Kaplan EL, Meier PI (1958) A nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
15. Katz MH, Bouvet M, Al-Refaie W et al (2004) Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis. Hepatogastroenterology 51:842-846 (Pubitemid 38590979)
16. Yeo CJ, Sohn TA, Cameron JL et al (1998) Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227:821-831 (Pubitemid 29119529)
17. Jarufe NP, Coldham C, Mayer AD et al (2004) Favorable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 21: 202-209 (Pubitemid 39070131)
18. Abrams RA, Grochow LB, Chakravarthy A et al (1999) Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys 44:1039-1046
19. Chakravarthy A, Abrams RA, Yeo CJ et al (2000) Intensifi ed adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys 48:1089-1096
20. Breslin TM, Hess KR, Harbison DB et al (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123-132 (Pubitemid 32199408)
21. Regine WF, Abrams RA (1998) Adjuvant therapy for pancreatic cancer: back to the future. Int J Radiat Oncol Biol Phys 42:59-63 (Pubitemid 28435596)